OBJECTIVE
To evaluate the incidence, risk factors, and clinical outcomes associated with venous thromboembolism (VTE) in patients with gynecologic cancer treated with immune checkpoint inhibitors (ICI).
METHODS
This retrospective cohort study included patients with gynecologic malignancies treated with ICI at a singl...
Cassidy Abdeen, Jessica Sciuva, Reed M. O'Connor et al.· Gynecologic Oncology· 0 citations
OBJECTIVES
Clinical trials are essential to therapeutic advancement, yet access to trials in ovarian cancer may not be equitably distributed. This study evaluated associations between community-level social vulnerability and county-level availability of interventional ovarian cancer clinical trials in the United States...
Reed M. O'Connor, Jennifer A. Sinnott, Caitlin E. Meade et al.· Gynecologic Oncology· 0 citations
It is suggested that digital inequities may contribute to site- and age-specific disparities in gynecologic cancer survival, underscoring the need to address barriers to digital access as part of efforts to improve cancer outcomes.
Julia Chalif, Laura M. Chambers, Caitlin E. Meade et al.· International Journal of Gyn...· 0 citations
Delayed diagnosis of vulvar SCC was associated primarily with provider and healthcare system-related factors rather than patient or tumor characteristics, which may help facilitate more prompt diagnosis and therapeutic intervention.
Julia C. Sakach, Molly A. Morton, Jessica Velasquez et al.· Gynecologic Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.